GYPA and hepatocellular carcinoma: Our findings indicated an upregulation of GYPA and CLDN18 mRNA levels in hepatocellular carcinoma tissues, with CLDN18 expression elevated in hepatocellular carcinoma cell lines and GYPA expression increased in most hepatocellular carcinoma cell lines (Figure 10B; Supplementary Figure S1B).